Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica to Model Structures of GPCRs for Procter and Gamble Pharmaceuticals

NEW YORK, May 18 (GenomeWeb News) - Inpharmatica will develop computational structural models of families of human G-protein coupled receptors for Procter and Gamble Pharmaceuticals, the company said today.


Under the agreement, P&GP, a subsidiary of Procter and Gamble, will fund a research program at London-based Inpharmatica and will pay license fees for discoveries resulting from the project.


Inpharmatica will use its PharmaCarta platform to create computational structural models and to identify chemotypes for families of human G-protein coupled receptors.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.